118 related articles for article (PubMed ID: 37783290)
1. Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21-10).
Song JY; Moon SH; Suh YG; Kim JH; Oh D; Noh JM; Jeong JU; Cho IJ; Kang MK; Kim JH; Kim YS; Kim HJ; Park WY; Kim BH; Kim HJ
Radiother Oncol; 2023 Dec; 189():109936. PubMed ID: 37783290
[TBL] [Abstract][Full Text] [Related]
2. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
[TBL] [Abstract][Full Text] [Related]
3. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
Wang J; Wu Y; Zhang W; Chen Y; Liu Q; Jing S; Zhang J; Wu F; Wang J; Qiao X
Radiat Oncol; 2023 Aug; 18(1):142. PubMed ID: 37641149
[TBL] [Abstract][Full Text] [Related]
4. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
Liu T; Ding S; Dang J; Wang H; Chen J; Li G
Radiat Oncol; 2019 Oct; 14(1):176. PubMed ID: 31619265
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
[TBL] [Abstract][Full Text] [Related]
6. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
Ikawa T; Ishihara R; Matsueda K; Konishi K; Yamamoto S; Morimoto M; Kanayama N; Teshima T
BMC Cancer; 2022 Mar; 22(1):301. PubMed ID: 35313853
[TBL] [Abstract][Full Text] [Related]
7. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
[TBL] [Abstract][Full Text] [Related]
8. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.
Nakatani Y; Kato K; Shoji H; Iwasa S; Honma Y; Takashima A; Ushijima T; Ito Y; Itami J; Boku N
Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155
[TBL] [Abstract][Full Text] [Related]
9. Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang X; Li M; Meng X; Kong L; Zhang Y; Wei G; Zhang X; Shi F; Hu M; Zhang G; Yu J
Radiat Oncol; 2014 Feb; 9():64. PubMed ID: 24571804
[TBL] [Abstract][Full Text] [Related]
10. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.
Li Q; Zhu S; Li S; Deng W
Medicine (Baltimore); 2019 Jan; 98(3):e14080. PubMed ID: 30653123
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.
Uchinami Y; Myojin M; Takahashi H; Harada K; Shimizu S; Hosokawa M
Radiat Oncol; 2016 Jun; 11():84. PubMed ID: 27328734
[TBL] [Abstract][Full Text] [Related]
12. [Clinical outcomes of different irradiation ranges in definitive intensity-modulated radiotherapy for esophageal cancer].
Zhu SC; Li QF; Zhang XY; Deng WZ; Song CY; Wang X; Yan K
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1040-1047. PubMed ID: 33342161
[No Abstract] [Full Text] [Related]
13. Preliminary analysis of the benefits of different irradiation types on patients with postoperative locoregional recurrence of esophageal cell squamous carcinoma.
Gao HM; Shen WB; Zhang XY; Xu JR; Li YM; Li SG; Zhu SC
Ann Palliat Med; 2021 Sep; 10(9):9467-9479. PubMed ID: 34628872
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China.
Lyu J; Yisikandaer A; Li T; Zhang X; Wang X; Tian Z; Chen L; Lu B; Chen H; Yang J; Wang Q; Zhang J; Ma Y; Liu R; Liu R; Hage A; Lang J
Cancer Med; 2020 Oct; 9(20):7460-7468. PubMed ID: 32841543
[TBL] [Abstract][Full Text] [Related]
15. Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis.
Cheng YJ; Jing SW; Zhu LL; Wang J; Wang L; Liu Q; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ
J Radiat Res; 2018 Sep; 59(5):604-615. PubMed ID: 30085197
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
17. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
18. Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival.
Chen X; Zhang Y; Zhou X; Wang M; Na F; Zhou L; Xu Y; Zou B; Xue J; Liu Y; Gong Y
Front Oncol; 2023; 13():1274924. PubMed ID: 37886166
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute.
Jing W; Zhu H; Guo H; Zhang Y; Shi F; Han A; Li M; Kong L; Yu J
PLoS One; 2015; 10(12):e0143007. PubMed ID: 26636574
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Recurrence Patterns and Salvage Treatments After Definitive Radiotherapy for cT1a and cT1bN0M0 Esophageal Cancer.
Kawamoto T; Shikama N; Mine S; Sasai K
Front Oncol; 2022; 12():857881. PubMed ID: 35898896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
